In the media

<p>Meritxell Teixidó, IRB Barcelona</p>
25 Sep 2019 -

The newspaper La Razón has interviewed IRB Barcelona researcher Meritxel Teixidó in the context of the grant award ceremony of the ”la Caixa” Foundation, which was held on 16 September.Teixidó has received a CaixaImpulse grant to work towards the preclinical development of one of the compounds that shows the greatest therapeutic potential for a given type of pediatric brain cancer. “We know that drugs are necessary to treat these patients, but they can´t reach the brain in sufficient amounts. Greater amounts could be administered to ensure that the correct amount reaches the brain but this would cause many side effects,” explains Teixidó...

<p>Eduard Batlle, IRB Barcelona.</p>
25 Sep 2019 -

The newspaper ABC has interviewed Eduard Batlle, ICREA researcher and head of the Colorectal Cancer Lab at IRB Barcelona, one of the beneficiaries of funding from the ”la Caixa” Foundation in the Health Research category. Batlle’s project seeks to discover how tumour cells modify their environment to evade detection by the immune system, thus allowing the regeneration of the tumour. “We have confirmed that when tumour cells leave the primary tumour they are recognised by the immune system but they then evade surveillance and spread through the organism,” says the scientist.


Link to...

<p>”la Caixa” Fellowship award ceremony</p>
25 Sep 2019 -

The radio station Cadena SER and the newspapers ABC and El Punt Avui, among other media, have reported on the grant award ceremony of the ”la Caixa” Foundation, which was held on Monday 16 September. The beneficiaries of include IRB Barcelona researchers Eduard Batlle and Raúl Méndez, who were awarded funding for two projects in the Biomedicine and Health call, Meritxel Teixidó, who obtained a grant through the CaixaImpulse Programme, and Enrique Marcos, who received a postdoctoral ”la Caixa” fellowship.


Link to...

<p>Manuel Serrano, IRB Barcelona.</p>
18 Sep 2019 -

In the context of the Longevity World Forum, which will be held on 14 and 15 November in Barcelona, the specialised journal Acta Sanitaria has published an interview with IRB Barcelona researcher Manuel Serrano. “We want to understand how tissues respond to damage (and the word damage includes aging, degenerative diseases and cancer),” says the scientist.

Link to Acta Sanitaria


<p>Manuel Serrano, IRB Barcelona.</p>
18 Sep 2019 -

The newspapers ABC and La Vanguardia, and the radio station COPE, among other media, have reported on the international Geroscience gathering, which was held on 13 and 14 September in Madrid. This is the first time that this event has been hosted in Europe and, on this occasion, IRB Barcelona researcher Manuel Serrano was one of the organisers. Geroscience aims to increase knowledge of the aging process and to disseminate research breakthroughs in this field. “Science and research are not pursuing immortality but aim to improve the treatments of typical aging-associated diseases, with a focus on being able to maintain a satisfactory quality of life for...

<p>Structure of the portal proteins of Epstein-Barr virus. Cristina Machón, IRB Barcelona.</p>
3 Sep 2019 -

The newspaper La Vanguardia and the specialised journals SINC and Diario Médico, among other media, have published articles on two studies performed by researchers at IRB Barcelona and the Molecular Biology Institute of Barcelona (IBMB-CSIC). The studies describe the structure of the portal protein of the Epstein-Barr virus and bacteriophage T7, which is crucial for infection by these two viruses. Although the Epstein-Barr virus, which causes glandular fever (also known as mononucleosis) and various kinds of cancer, is one of the most common viruses found in humans, there is still no treatment available. “Understanding the structure of the portal protein could be useful for the design of...

<p>Differences between tumours in male and female vinegar flies. Cayetano González, IRB Barcelona.</p>
22 Aug 2019 -

The newspapers Público and El Punt Avui,and the TV channel La Sexta, among other media, have reported on a recent study headed by Cayetano González, ICREA researcher at IRB Barcelona. Using the vinegar fly, Drosophila melanogaster, this study has identified possible regulators of the differences in tumours associated with the sex of an individual. Published in Science Advances, the study compares the brain tumours of male and female flies at the molecular level and identifies the protein responsible for the different degrees of aggressiveness. Understanding the molecular bases of the differences in the incidence of cancer and survival between men and women is crucial if specific and more...

<p>Interaction of the androgen receptor and chaperone Hsp70 (in red) inside the cell. Blue indicates cell nuclei. Xavier Salvatella, IRB Barcelona.</p>
14 Aug 2019 -

The radio station COPE, the newspaper ABC, RTVE and the scientific news agency SINC, among other media, have echoed news about a study led by Xavier Salvatella, head of the Molecular Biophysics Laboratory at IRB Barcelona. This study indicates that chaperone protein Hps70 could be an attractive therapeutic target for the treatment of Kennedy’s disease, a rare neuromuscular disorder, as well as castration-resistant prostate cancer.

Link to COPE

Link to ABC 


<p>The escape room “The #MetastasisChallenge against the clock” organised by IRB Barcelona.</p>
29 Jul 2019 -

TVE, the local TV channel Betevé and the newspaper La Vanguardia, among other media, have echoed on news about an escape room, “The #MetastasisChallenge against the clock”, organised by IRB Barcelona. In this game, participants have to solve a scientific puzzle in a real research lab. The proceeds from this activity will go to the #MetastasisChallenge, IRB Barcelona’s fundraising campaign in support of biomedical research into this disease.

Link to TVE

Link to Betevé


<p>Structure of a blood vessel. Raquel Batlle, IRB Barcelona.</p>
25 Jul 2019 -

RAC1, La Sexta and the newspapers La Vanguardia and ABC, among other media, have echoed on news of a study done by researchers of IRB Barcelona that has demonstrated that the p38 protein regulates the formation of new blood vessels in tumours. A greater understanding of how the development of new blood vessels is regulated may help to improve chemotherapy treatments for cancer. 

Link to RAC1 

Link to ...